{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:16Z","timestamp":1786997896888,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.urolonc.2010.08.008","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T12:17:05Z","timestamp":1299673025000},"page":"427-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Imaging of prostate cancer with PET\/CT and radioactively labeled choline derivates"],"prefix":"10.1016","volume":"31","author":[{"given":"Bernd Joachim","family":"Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Souvatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Treiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2010.08.008_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000019923","article-title":"Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy","volume":"36","author":"Hofer","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib2","first-page":"46","article-title":"Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer","volume":"43","author":"Nunez","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0090-4295(02)01509-1","article-title":"Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer","volume":"59","author":"Morris","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00259-006-0163-x","article-title":"(11)C-acetate PET in the early evaluation of prostate cancer recurrence","volume":"34","author":"Albrecht","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00259-005-1764-5","article-title":"Positron tomographic assessment of androgen receptors in prostatic carcinoma","volume":"32","author":"Dehdashti","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s002590000309","article-title":"Experience with carbon-11 choline positron emission tomography in prostate carcinoma","volume":"27","author":"Kotzerke","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib7","first-page":"366","article-title":"Tumor localization of 16beta-18F-fluoro-5\u03b1-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer","volume":"45","author":"Larson","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.ju.0000148326.71981.44","article-title":"Detection of prostate cancer with 11C-methionine positron emission tomography","volume":"173","author":"Toth","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib9","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.03.5279","article-title":"11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer","volume":"24","author":"Wachter","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jcb.10659","article-title":"Choline phospholipid metabolism: A target in cancer cells?","volume":"90","author":"Ackerstaff","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.urolonc.2010.08.008_bib11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00261-006-9029-8","article-title":"Prostate cancer: Value of magnetic resonance spectroscopy 3D chemical shift imaging","volume":"31","author":"Casciani","year":"2006","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.onc.1205144","article-title":"Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K","volume":"21","author":"Ramirez de Molina","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2010.08.008_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0006-291X(02)00920-8","article-title":"Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers","volume":"296","author":"Ramirez de Molina","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.urolonc.2010.08.008_bib14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.198.3.8628874","article-title":"Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24\u20130.7 cm3) spatial resolution","volume":"198","author":"Kurhanewicz","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.neo.7900081","article-title":"Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer","volume":"2","author":"Kurhanewicz","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.urolonc.2010.08.008_bib16","first-page":"3599","article-title":"Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells","volume":"61","author":"Ackerstaff","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2010.08.008_bib17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2310\/7290.2006.00032","article-title":"choline transporter as a novel target for molecular imaging of cancer","volume":"5","author":"Hara","year":"2006","journal-title":"Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib18","first-page":"1375","article-title":"Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method","volume":"16","author":"Katz-Brull","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2010.08.008_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/abbi.1995.9959","article-title":"Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines","volume":"323","author":"Ratnam","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.urolonc.2010.08.008_bib20","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00259-009-1117-x","article-title":"Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment","volume":"36","author":"M\u00fcller","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib21","first-page":"1215","article-title":"PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine","volume":"38","author":"Haberkorn","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib22","doi-asserted-by":"crossref","unstructured":"Holzapfel K, Muller SA, Seidl C, et al. Effects of irradiation on the [methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3. Strahlenther Onkol 184:319-24.","DOI":"10.1007\/s00066-008-1799-1"},{"key":"10.1016\/j.urolonc.2010.08.008_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0302-2838(02)00129-X","article-title":"Visualization of prostate cancer with 11C-choline positron emission tomography","volume":"42","author":"de Jong","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib24","first-page":"1642","article-title":"Detection and localization of prostate cancer: Correlation of (11)C-choline PET\/CT with histopathologic step-section analysis","volume":"46","author":"Farsad","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00259-008-0716-2","article-title":"[(11)C]choline uptake with PET\/CT for the initial diagnosis of prostate cancer: Relation to PSA levels, tumor stage and anti-androgenic therapy","volume":"35","author":"Giovacchini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ju.0000142099.80156.85","article-title":"Prostate cancer localization with 18fluorine fluorocholine positron emission tomography","volume":"173","author":"Kwee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib27","first-page":"262","article-title":"Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET","volume":"47","author":"Kwee","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2006.04.015","article-title":"11C-choline positron emission tomography\/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy","volume":"176","author":"Martorana","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib29","first-page":"1249","article-title":"Imaging prostate cancer with 11C-choline PET\/CT","volume":"47","author":"Reske","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00259-006-0190-7","article-title":"Value of 11C-choline PET and PET\/CT in patients with suspected prostate cancer","volume":"34","author":"Scher","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiol.2352040494","article-title":"Fluorocholine PET\/CT in patients with prostate cancer: Initial experience","volume":"235","author":"Schmid","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00259-003-1377-9","article-title":"Kinetics of [(11)C]choline uptake in prostate cancer: A PET study","volume":"31","author":"Sutinen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00259-004-1755-y","article-title":"Prostate cancer: A comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy","volume":"32","author":"Yamaguchi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000083551","article-title":"11C-choline positron emission tomography in prostate cancer: Primary staging and recurrent site staging","volume":"74","author":"Yoshida","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2010.08.008_bib35","first-page":"331","article-title":"Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET","volume":"44","author":"de Jong","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.eururo.2008.04.030","article-title":"11C-choline positron emission tomography\/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: Comparison with clinical staging nomograms","author":"Schiavina","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nucmedbio.2008.05.006","article-title":"[(11)C]choline positron emission tomography\/computed tomography for staging and restaging of patients with advanced prostate cancer","volume":"35","author":"Tuncel","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(02)02526-8","article-title":"Time trends in biochemical recurrence after radical prostatectomy: Results of the SEARCH database","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-5347(05)63946-8","article-title":"Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer","volume":"169","author":"Han","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijrobp.2003.10.059","article-title":"A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy","volume":"59","author":"Chism","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2010.08.008_bib41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0025-6196(11)62406-3","article-title":"PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer","volume":"76","author":"Roberts","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urolonc.2010.08.008_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.pcan.4500732","article-title":"Management of recurrent disease after radical prostatectomy","volume":"7","author":"Bott","year":"2004","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2010.08.008_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0090-4295(99)80421-X","article-title":"Local recurrence after radical prostatectomy: Characteristics in size, location, and relationship to prostate-specific antigen and surgical margins","volume":"47","author":"Connolly","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib44","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0090-4295(99)00351-9","article-title":"Vesico-urethral anastomosis biopsy after radical prostatectomy: Predictive value of prostate-specific antigen and pathologic stage","volume":"54","author":"Shekarriz","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1259\/bjr.70.838.9404201","article-title":"Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy","volume":"70","author":"Kramer","year":"1997","journal-title":"Br J Radiol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2332032086","article-title":"Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience","volume":"233","author":"Coakley","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.2312030011","article-title":"Suspected local recurrence after radical prostatectomy: Endorectal coil MR imaging","volume":"231","author":"Sella","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0001-2998(97)80042-6","article-title":"PET in oncology: Will it replace the other modalities?","volume":"27","author":"Hoh","year":"1997","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib49","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2214\/ajr.167.6.8956585","article-title":"Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence","volume":"167","author":"Jager","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/radiology.190.2.8284375","article-title":"Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: Prospective study of 285 patients","volume":"190","author":"Oyen","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib51","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","article-title":"Influence of trigger PSA and PSA kinetics on 11C-choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy","volume":"50","author":"Castellucci","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0302-2838(03)00207-0","article-title":"11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer","volume":"44","author":"de Jong","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11307-005-0023-2","article-title":"Positron emission tomography\/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: Meaningful at PSA < 5 ng\/ml?","volume":"8","author":"Heinisch","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","article-title":"Evaluation of [(18)F]-choline PET\/CT for staging and restaging of prostate cancer","volume":"35","author":"Husarik","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","article-title":"The detection rate of [11C]choline-PET\/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib56","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/01.ju.0000056901.95996.43","article-title":"Value of [11C]choline-positron emission tomography for re-staging prostate cancer: A comparison with [18F]fluorodeoxyglucose-positron emission tomography","volume":"169","author":"Picchio","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00259-007-0530-2","article-title":"[11C]choline PET\/CT imaging in occult local relapse of prostate cancer after radical prostatectomy","volume":"35","author":"Reske","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib58","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1464-410X.2007.07083.x","article-title":"Evaluation of [11C]-choline positron-emission\/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer","volume":"100","author":"Rinnab","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2010.08.008_bib59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2007.03.032","article-title":"Detection of lymph-node metastases with integrated [11C]choline PET\/CT in patients with PSA failure after radical retropubic prostatectomy: Results confirmed by open pelvic-retroperitoneal lymphadenectomy","volume":"52","author":"Scattoni","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib60","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","article-title":"[18F]fluorocholine PET\/CT imaging for the detection of recurrent prostate cancer at PSA relapse: Experience in 100 consecutive patients","volume":"33","author":"Cimitan","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1095-0397(00)00056-X","article-title":"Using PET 18F-FDG, 11CO, and 15O-water for monitoring prostate cancer during a phase II anti-angiogenic drug trial with thalidomide","volume":"3","author":"Kurdziel","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00006231-200109000-00004","article-title":"FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation","volume":"22","author":"Oyama","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.urolonc.2010.08.008_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1095-0397(00)00059-5","article-title":"Preliminary Evaluation of F-18 fluorocholine (FCH) as a PET tumor imaging agent","volume":"3","author":"Coleman","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib64","first-page":"S218","article-title":"Monitoring of Docetaxel Therapy Response in a Mouse Prostate Xenograft Tumor Model by [11C]choline PET\/CT","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2010.08.008_bib65","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.2967\/jnumed.108.057273","article-title":"Monitoring predominantly cytostatic treatment response with 18F-FDG PET","volume":"50","author":"Contractor","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/RLU.0b013e318184b3a0","article-title":"C-11 choline PET\/CT imaging for differentiating malignant from benign prostate lesions","volume":"33","author":"Li","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib67","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1464-410X.2007.06772.x","article-title":"18F-choline and\/or 11C-acetate positron emission tomography: Detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng\/ml) after radical prostatectomy","volume":"99","author":"Vees","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2010.08.008_bib68","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11547-008-0263-8","article-title":"Role of whole-body 18F-choline PET\/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer","volume":"113","author":"Pelosi","year":"2008","journal-title":"Radiol Med"},{"key":"10.1016\/j.urolonc.2010.08.008_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3413\/nukmed-0194","article-title":"3-Phasen-PET\/CT mit 18F-Fluor-Cholin zur Evaluation des Prostatakrebsrezidivs","volume":"48","author":"Steiner","year":"2009","journal-title":"Nuklearmedizin"},{"issue":"Suppl","key":"10.1016\/j.urolonc.2010.08.008_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1569-9056(07)60820-3","article-title":"11C-choline-positron emission tomography\/computerized tomographyY (11C-PET\/CT) for tumor localization of locally recurrent prostate cancer after radiation therapy","volume":"6","author":"Ohlmann","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib71","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijrobp.2009.04.090","article-title":"Detection of local, regional, and distant recurrence in patients with PSA relapse after external-beam radiotherapy using (11)C-choline positron emission tomography","volume":"77","author":"Breeuwsma","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2010.08.008_bib72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000144059","article-title":"[11C]choline PET\/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer","volume":"81","author":"Rinnab","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2010.08.008_bib73","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00345-009-0371-7","article-title":"[(11)C]choline PET\/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy","volume":"27","author":"Rinnab","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib74","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","article-title":"Predictive factors of [(11)C]choline PET\/CT in patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.urolonc.2010.08.008_bib75","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0090-4295(00)00824-4","article-title":"Multicenter ProstaScint imaging findings in 2,154 patients with prostate cancer","volume":"56","author":"Sodee","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.08.008_bib76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3121\/cmr.2007.740","article-title":"The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients","volume":"5","author":"Jani","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.urolonc.2010.08.008_bib77","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1998.16.1.284","article-title":"Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy","volume":"16","author":"Kahn","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib78","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2003.05.138","article-title":"Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy","volume":"21","author":"Thomas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.08.008_bib79","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2006.09.026","article-title":"Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer","volume":"67","author":"Nagda","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910002243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910002243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:59:57Z","timestamp":1761040797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143910002243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1078143910002243"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.08.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of prostate cancer with PET\/CT and radioactively labeled choline derivates","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}